ArticleContemporary oncology (Poznan, Poland)2022
Trends of colorectal cancer in a central area of Iran during 2009-2014. An application of joinpoint regression.
Article in Contemporary oncology (Poznan, Poland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Incidence of colorectal cancer in Iran: A systematic review and meta-analysis.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Colorectal cancer (CRC) has become a major public health concern. We analysed current CRC statistics in Arak, including the estimated number of new cases among males and females, age standardized rates (ASRs), and trends for cases diagnosed in the period 2009-2014. Material and methods: In this study, reported cases of CRC from 2009 through 2014 for Arak residents were obtained from the Arak cancer registry database. We used the direct method to calculate annual ASRs. Joinpoint regression was performed on the ASRs for the whole study period, and we calculated the annual percentage changes (APC). Results: 533 new CRC cases were included. The annual ASRs of CRC per 100,000 population during 2009-2014 were 13.58 (95% CI: 11.9-15.42), 16.52 (95% CI: 14.62-18.60), 15.00 (95% CI: 13.72-16.35) for females, males, and both genders, respectively. Females had an increasing trend in ASRs (APC: 10.25% and CI 95%: -0.79 to 22.53), and a slightly increasing trend was observed among males (APC = 5.03% and CI 95%: -6.14 to 17.53). Conclusions: The increasing trend was higher among females than males. These findings raise considerable concern related to a crucial growing public health problem in Arak. They were higher than the averages of ASRs in all of Iran. Furthermore, any increase in the ASRs of CRC may be due to the promotion and improvement in the quality of the cancer registry over time. It is recommended that the quality of the cancer registry is promoted more than the former.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.